By Viraj Gandhi
The pharmaceutical landscape continues to evolve rapidly, propelled forward by advanced automation and technologies that are transforming drug manufacturing. At Medivant Healthcare, we have witnessed firsthand how deeply these innovations can impact production through enhanced precision, scalability, sustainability, and more. In this article, we explore the key benefits that automation and technology offer to drive quality, efficiency, and progress in pharmaceutical manufacturing.
A major advantage of automation is the unprecedented level of accuracy and consistency it enables in the production process. Automated systems, following meticulously programmed algorithms, achieve a degree of precision challenging for manual methods. This results in remarkably consistent drug doses that meet specifications perfectly for safety and efficacy. For patients, this means reliable medications that perform as expected every time.
Additionally, automation facilitates flexible scalability, allowing output to be increased to meet growing global demand without compromising on quality. Medivant Healthcare’s automated lines can generate up to 10 million injectable vials annually, helping prevent shortages of essential medicines.
While adopting automation requires an upfront investment, the long-term savings are substantial. Automated equipment can run continuously, maximizing production hours and output. Manual labor needs are reduced, cutting associated costs & errors thereby decreasing product risk. Precision processes also minimize waste.
Automation also enhances pharmaceutical quality through sterility assurance. Highly controlled automated environments carry much lower risks of human error and contamination. At Medivant Healthcare, our automated facility integrates the latest technologies for contamination prevention and quality control.
Modern automation systems also enable advanced data collection tools and real-time monitoring. The generated insights support production optimization, quality assurance, regulatory compliance, preventive maintenance and more. As we continue implementing the newest technologies, our data-driven capabilities will expand alongside.
Additionally, by enabling agile, high-volume production, automation can help tackle drug shortages. Medivant Healthcare is leveraging our automated capacity to produce essential injectables on the FDA shortage list, improving availability for patients.
Automation also accelerates pharmaceutical research and development. The vast datasets collected provide invaluable learnings around formulations, parameters, interactions, and more to inform the development of new therapies. As an innovative company, Medivant actively explores emerging technologies to unlock R&D potential.
Automation and technology constitute a new chapter in achieving manufacturing excellence. At Medivant Healthcare, we take pride in spearheading this transformation to deliver high-quality, affordable generics to patients worldwide. As we integrate the latest innovations, we remain committed to pushing new boundaries in pharmaceutical progress.
In 2018, Viraj Gandhi founded Medivant Healthcare drawing upon his 25 vears of pharmaceutical manufacturing & sales experience. Viraj has been involved in helping build 3 pharmaceutical companies internationally in his career. Leveraging his vast experience, Viraj identified a unique opportunity to meet large scale demand for generic medications reliably, affordably, and efficiently by building a fully automated, state of the art manufacturing facility in Chandler, Arizona. Hailing from Mumbai, India, Viraj led the growth of Medicine Shoppe India in his home country, growing the company to be the second largest pharmacy chain in all of India under his tenure as CEO while managing over 1,200 employees.
